[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606437":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":35,"responsibleParty":53,"collaborators":57,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":75,"sex":81,"minAge":82,"maxAge":18,"enrollmentInfo":83,"targetDuration":18,"studyType":86,"phases":87,"briefSummary":89,"conditions":90,"keywords":97,"overallStatus":101,"whyStopped":18,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":111},{"fullName":5,"class":6},"Lusofona University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Mobili® device (Intervention Group)","EXPERIMENTAL","Group of patients using the Mobili® device",[13],"Device: Independent use of the Mobili® Device by patients, overseen by pharmacists",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo (Control Group)","NO_INTERVENTION","Group of patients using the current Dose Administration Aid system available in the pharmacy",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DEVICE","Independent use of the Mobili® Device by patients, overseen by pharmacists","After recruitment each participant will be subject to a type I medication review.\n\nAfter allocation to the intervention group, pharmacists will provide initial training to participants, and during the course of the intervention whenever necessary (e.g. when delivering the eDosette with the therapeutic regime). Pharmacists will prepare the eDosette in the pharmacy and deliver it directly to participants with no further intervention.\n\nParticipants will receive the number of eDosettes their therapeutic regime allows, to minimize visits to the pharmacy. For the control group, pharmacists will also provide the number of DAAs the therapeutic regime allows. Upon finishing the intervention, a new type II medication review will be performed for all participants (intervention and control) and information related to their personal therapeutic regime will be provided, ensuring a safe exit of the study.",[9],[26],{"name":27,"affiliation":28,"role":29},"João Pedro B Gregório, PharmD PhD","COFAC - Cooperativa Cooperativa de Animação e Formação Cultural, C.R.L","PRINCIPAL_INVESTIGATOR",[31],{"name":27,"role":32,"phone":33,"phoneExt":18,"email":34},"CONTACT","+351217515500","joao.gregorio@ulusofona.pt",[36],{"facility":37,"status":18,"city":38,"state":18,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Universidade Lusófona - Centro Universitário de Lisboa","Lisbon","1749-024","Portugal","PT",{"type":43,"coordinates":44},"Point",[45,46],-9.1498,38.72509,{"lat":46,"lon":45},[49],{"name":50,"role":32,"phone":33,"phoneExt":51,"email":52},"Luís M Rodrigues","629","monteiro.rodrigues@ulusofona.pt",{"type":29,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":56,"oldNameTitle":18,"oldOrganization":18},"João Pedro Bernardo Gregório","PI","Universidade Lusófona de Humanidades e Tecnologias",[58,61,63,65,67,69,71],{"name":59,"class":60},"CBIOS - Research Center for Biosciences & Health Technologies","UNKNOWN",{"name":62,"class":60},"MedThings",{"name":64,"class":60},"Associação Nacional das Farmácias",{"name":66,"class":6},"University of Oslo",{"name":68,"class":60},"Universidade de Trás-os-Montes e Alto Douro",{"name":70,"class":60},"GHTM - Global Health and Tropical Medicine",{"name":72,"class":60},"COFAC Cooperativa de Formacao e Animacao Cultural CRL (Portugal)","100606437","testing-a-smart-medication-dispenser-mobili-to-help-people-with-chronic-conditions-take-their-medicine-100606437",false,"NCT07175545","Testing a Smart Medication Dispenser (Mobili®) to Help People With Chronic Conditions Take Their Medicine","Enhancing Medication Adherence With Mobili®: A Crossover Randomized Controlled Trial in Portuguese Community Pharmacies","MobiMAd@PT RCT","Inclusion Criteria:\n\n* Aged 18 years and above\n* Non-institutionalized diabetes and cardiovascular disease patients\n* At least two medications in the therapeutic regimen\n* Requiring only regular oral medication that can be dispensed in the eDosette\n* Able to handle the use of technological devices (i.e. smartphones)\n\nExclusion Criteria:\n\n* Cognitive impairments preventing independent use of Mobili®\n* Patients using medicines that do not fit or are incompatible with being dispensed in the eDosette (i.e. some capsules, solutions, insulins or GLP-1 analogues, transdermal patches, eye-drops)\n* One participant per household","ALL","18 Years",{"count":84,"type":85},96,"ESTIMATED","INTERVENTIONAL",[88],"NA","Medication adherence is one of the biggest challenges faced by healthcare systems, especially among people with multiple chronic diseases who take several medications daily. Studies show that up to half of patients do not take their medication as prescribed, which can compromise treatment effectiveness, increase complications, and lead to waste of healthcare resources.\n\nIn this context, several solutions have been developed to help patients organize their therapy, such as dose administration aids (DAAs) used in pharmacies. However, many of these systems are manual, inflexible, or difficult to use.\n\nThis study is part of the MobiMAd@PT project, which will evaluate Mobili®, a portable digital medication dispenser developed in Norway. Mobili® allows patients to automatically receive the right medication at the right time and comes with a real-time monitoring system, enabling healthcare professionals to detect missed doses and provide timely support.\n\nThe main goal of this study is to assess the effectiveness of Mobili® in improving medication adherence among patients with polypharmacy in Portugal and to understand whether this type of technology can be useful and applicable in the context of Portuguese community pharmacies. Your participation will contribute to the development of new ways to manage health at home, with the support of pharmacists and technology.",[91,92,93,94,95,96],"Dose Administration Aids","Medication Adherence","Polypharmacy","Technology in Health","Diabetes","Cardiovascular Diseases",[98,92,99,100],"Digital Health","Automatic Medicine Dispenser","Community Pharmacy","NOT_YET_RECRUITING","2025-09-08",{"date":104,"type":105},"2025-09-16","ACTUAL",{"date":107,"type":85},"2025-10-15",{"date":109,"type":85},"2026-06-30",{"name":5,"class":6},1]